Commonwealth Bank of Australia’s Pfizer PFE Stock Holding History

Commonwealth Bank of Australia’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-857,024	Closed	-$35.2M	–	697
2019 Q2	$35.2M	Sell	857,024 -191,581	-18%	-$7.61M	0.34%	58
2019 Q1	$42.2M	Buy	1,048,605 +168,724	+19%	+$6.76M	0.4%	51
2018 Q4	$36.4M	Buy	879,881 +69,905	+9%	+$2.9M	0.4%	50
2018 Q3	$33.9M	Buy	809,976 +1,792	+0.2%	+$69K	0.33%	60
2018 Q2	$27.8M	Buy	808,184 +56,305	+7%	+$1.92M	0.28%	64
2018 Q1	$25.3M	Sell	751,879 -124,489	-14%	-$4.28M	0.27%	66
2017 Q4	$30.1M	Sell	876,368 -18,275	-2%	-$623K	0.3%	72
2017 Q3	$30.3M	Buy	894,643 +41,653	+5%	+$1.34M	0.29%	68
2017 Q2	$27.2M	Buy	852,990 +30,699	+4%	+$968K	0.27%	73
2017 Q1	$26.7M	Sell	822,291 -21,686	-3%	-$684K	0.29%	74
2016 Q4	$26M	Buy	843,977 +41,349	+5%	+$1.26M	0.32%	70
2016 Q3	$25.8M	Sell	802,628 -45,955	-5%	-$1.54M	0.31%	68
2016 Q2	$28.4M	Sell	848,583 -23,591	-3%	-$753K	0.33%	58
2016 Q1	$24.5M	Buy	872,174 +48,028	+6%	+$1.37M	0.3%	62
2015 Q4	$25.2M	Sell	824,146 -27,802	-3%	-$875K	0.32%	69
2015 Q3	$25.4M	Sell	851,948 -762	-0.1%	-$24.4K	0.32%	72
2015 Q2	$27.1M	Buy	852,710 +24,204	+3%	+$789K	0.36%	59
2015 Q1	$27.3M	Buy	828,506 +421	+0.1%	+$13.4K	0.37%	69
2014 Q4	$24.5M	Sell	828,085 -45,822	-5%	-$1.31M	0.35%	64
2014 Q3	$24.5M	Buy	873,907 +38,682	+5%	+$1.09M	0.32%	75
2014 Q2	$23.5M	Sell	835,225 -1,769,506	-68%	-$50.4M	0.32%	71
2014 Q1	$79.4M	Sell	2,604,731 -583,728	-18%	-$17.4M	0.51%	45
2013 Q4	$92.7M	Sell	3,188,459 -1,329,882	-29%	-$38.7M	0.64%	28
2013 Q3	$123M	Sell	4,518,341 -438,214	-9%	-$11.9M	0.89%	18
2013 Q2	$132M	Buy	+4,956,555	New	+$137M	0.99%	18

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Commonwealth Bank of Australia's PFE Position: Q3 2019 in Review

Commonwealth Bank of Australia sold out of Pfizer (PFE) in Q3 2019, closing a stake of 857,024 shares — an estimated $35.2M sold.

Commonwealth Bank of Australia first reported a position in PFE in Q2 2013 and held it in 25 quarters. The position peaked at $132M in Q2 2013. 2,323 funds tracked by Wall St. Rank hold PFE as of Q3 2019.

Commonwealth Bank of Australia reported no remaining Pfizer position as of Q3 2019 after selling out during the quarter.
Commonwealth Bank of Australia sold 857,024 Pfizer shares in Q3 2019, an estimated $35.2M.
Commonwealth Bank of Australia first reported a position in Pfizer in Q2 2013 and held it in 25 quarters.
Commonwealth Bank of Australia's Pfizer position peaked at $132M in Q2 2013.
2,323 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.

Based on Commonwealth Bank of Australia's 13F filing for Q3 2019.